Showing results (1191-1200 of 5,695) with videos related to

Sort By:
Pageof 570
The Oncologist|June 17, 2024
Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancerMadappa N Kundranda, Ariane C Kemkes, Mark C Evans, et al.
The Oncologist|June 22, 2024
Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patientsMingda Wang, Guojun Qian, Hongmei Xiao, et al.
The Oncologist|June 24, 2024
Dose delay, dose reduction, and early treatment discontinuation in Black and White women receiving chemotherapy for nonmetastatic breast cancerMoriah Forster, Allison M Deal, Annie Page, et al.
The Oncologist|June 17, 2024
TRIUMPH: phase II trial of rucaparib monotherapy in patients with metastatic hormone-sensitive prostate cancer harboring germline homologous recombination repair gene mutationsMark C Markowski, Cora N Sternberg, Hao Wang, et al.
The Oncologist|June 5, 2024
Metastatic extraneural glioblastoma diagnosed with molecular testingNazanin K Majd, Henry Hiep Vo, Cesar A Moran, et al.
The Oncologist|June 4, 2024
Complete response to capmatinib in a patient with metastatic lung adenocarcinoma harboring CD47-MET fusion: a case reportGlaucia Alves de Souza, Debora Maciel Santana Dornellas, Paulo Vidal Campregher, et al.
The Oncologist|May 30, 2024
Health-related quality-of-life analysis from KEYNOTE-590: pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancerWasat Mansoor, Seongjung Joo, Josephine M Norquist, et al.
The Oncologist|June 13, 2024
Clinical outcomes of image-guided therapies in patients with adrenocortical carcinoma: a tertiary referral center retrospective studyBrenda Chahla, Koustav Pal, Vania Balderrama-Brondani, et al.
The Oncologist|June 13, 2024
Results of the Dutch scalp cooling registry in 7424 patients: analysis of determinants for scalp cooling efficacyToni S Brook, Tanja Seetsen, Marcus W Dercksen, et al.
The Oncologist|May 8, 2024
Longitudinal trajectories of a claims-based frailty measure during adjuvant chemotherapy in women with stage I-III breast cancerEmilie D Duchesneau, Katherine Reeder-Hayes, Til Stürmer, et al.
Pageof 570